One of the largest Indian pharmaceutical firm, Ranbaxy could get damaged by law suit for maintaining an expired patent `652 on pack insert of product Exelderm (Sulconazole nitrate). The patent `652 had already expired in October 1996. Ranbaxy could be charged for false patent marking.
This is the second case in this month after the case of Watson lab where the company has listed expired patents for its Androderm testosterone deficiency treatment.
No comments:
Post a Comment